Skip to main content
REPL logo

Replimune Group, Inc.

REPLNASDAQHealthcareBiotechnology

$12.47Today:- (-)1Y +42.40%

As of Oct 26, 2026 close

Market cap
$1.21B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.50$16.33
Volume (live)
-
Avg. volume (3M)
1.96M

Replimune Group (REPL) Income Statement

In fiscal 2026 (fiscal year ended Mar 31, 2026), Replimune Group posted a net loss of $313.94M, compared with a net loss of $247.30M a year earlier.

Replimune Group Income Statement Analysis

Values in millions USD

Scroll to see more
Replimune Group, Inc. income statement - Annual data in millions USD
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Revenue & Gross Profit
Revenue0.000.000.000.000.000.000.000.000.000.00
Cost of Revenue0.000.000.000.004.584.140.000.150.110.12
Gross Profit0.000.000.000.00-4.58-4.140.00-0.15-0.11-0.12
Operating Expenses
Research & Development221.18189.45174.96123.1980.6557.4938.7622.1713.526.94
Selling, General & Administrative98.740.0059.8150.9736.2621.1317.448.775.712.71
Operating Expenses319.92261.63232.85177.08116.9178.6256.2028.4216.968.21
Operating Income-319.92-261.63-232.85-177.08-121.48-82.76-56.20-30.95-19.23-9.65
Other Income/Expense
Interest Income13.6321.1223.3610.010.390.922.422.590.290.03
Interest Expense8.867.896.66-4.162.223.061.920.000.000.00
Other Income/Expense5.4314.8024.133.080.28-0.923.570.11-0.471.94
Income
Income Before Tax-314.49-246.83-215.39-174.00-121.21-83.68-52.63-30.83-19.70-7.70
Income Tax Expense-0.550.470.410.29-3.17-2.810.000.000.000.00
Net Income-313.94-247.30-215.79-174.28-118.04-80.87-52.63-30.83-19.70-7.70
Net Income - Continuous Operations-313.94-247.30-215.79-174.28-118.04-80.87-52.63-30.83-19.70-7.70
Net Income - Discontinued Operations----------
EBITDA-302.30-253.92-206.07-171.72-114.41-76.48-52.58-30.69-16.85-8.08
EBIT-318.32-238.94-208.73-174.17-115.14-79.96----
Depreciation & Amortization3.335.932.662.454.584.140.530.150.110.12
Earnings Per Share
Basic EPS-3.00-3.00-3.00-3.00-2.00-2.00-2.00-1.00-1.00-
Diluted EPS-3.00-3.00-3.00-3.00-2.00-2.00-2.00-1.00-1.00-
Basic Shares Outstanding92.8080.5666.5758.2152.2146.2534.2623.2030.8421.51
Diluted Shares Outstanding92.8080.5666.5758.2152.2146.2534.2623.2030.8430.84

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Replimune Group Financial Statements

Is Replimune Group profitable?

No. Replimune Group reported a net loss of $313.94M in fiscal 2026. In fiscal 2025 it lost $247.30M.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition